Orthopedics 2018

The global Rheumatology market for Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. RA is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. The research is being done in the development of IL-6 inhibitors, JAK inhibitors, BTK inhibitors. Orthopedics 2018 comes with a motive of “Advancement of the Innovative Drugs”. Orthopedics 2018 is a place for sharing the knowledge by the different presentations like oral, poster. It is an open platform for all the Surgeons, Physicians, Researchers, Scholars, and Students & Exhibitors to put forth their ideas in the field of Rheumatology.

About Pulsus: Pulsus is a publisher of scientific, technical, and medical journals. Pulsus established in 1984, headquartered in London, UK and with its offices in Ontario, Canada and Hyderabad, India. Pulsus acquired Andrew John Publishing and openaccessjournals.com to expand publishing and conducting global medical meetings under cmesociety.com banner.   Endorsed by medical societies, Pulsus Group is an ardent supporter of international medical research, and publishes 50+ journals in association with 20+ International medical and scientific societies. With immense please and support, Pulsus is proud to announce 10th International Conference on Orthopedics, Trauma and Rheumatology. Orthopedics-2018 Conference highlights the theme “Emerging Interventions in Orthopedics”. Orthopedics 2018 is an event intended to provide an exclusive platform for new researchers, scholars, rheumatologists, orthopedicians, physicians, students and educators to present and discuss the most recent innovations, trends, and concerns, practical trials faced and the solutions adopted in the concerned field.